Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
$54.19
+0.7%
$54.64
$47.56
$55.74
$1.99B0.62258,266 shs116,916 shs
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$79.30
$79.33
$64.89
$82.62
$154.64M1.225,442 shs1,179 shs
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$0.16
$0.20
$3.30
$419K1.23.04 million shs16,105 shs
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
-0.30%+0.62%-2.76%+1.09%+8.34%
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
-0.45%+2.37%-1.23%+2.81%+18.52%
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
0.00
N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
0.00
N/A$87.5810.44% Upside
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
$146.07M0.00N/AN/A($14.77) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/A17.21N/AN/AN/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/A11.74N/AN/AN/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
-$77.14MN/A0.00N/AN/A-59.70%N/A-37.01%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
$1.081.99%N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
$1.481.87%N/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/AN/AN/AN/AN/A

Latest PTX, AOR, FAB, and C4XD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
Quarterly$0.24303/21/20243/22/20243/28/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/AN/AN/A
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
N/AN/AN/A
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/A
1.08
0.92

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Core Growth Allocation ETF stock logo
AOR
iShares Core Growth Allocation ETF
N/A36.80 millionN/ANot Optionable
First Trust Multi Cap Value AlphaDEX Fund stock logo
FAB
First Trust Multi Cap Value AlphaDEX Fund
147,0001.95 millionN/ANot Optionable
Pernix Therapeutics Holdings, Inc. stock logo
PTX
Pernix Therapeutics
N/A14.51 millionN/AOptionable

PTX, AOR, FAB, and C4XD Headlines

SourceHeadline
Bicycle Therapeutics PLC ADR BCYCBicycle Therapeutics PLC ADR BCYC
morningstar.com - February 23 at 11:30 AM
Alcoholic HepatitisAlcoholic Hepatitis
medscape.com - July 25 at 2:14 PM
Prescient Therapeutics LtdPrescient Therapeutics Ltd
reuters.com - September 26 at 4:20 AM
Those who invested in Prescient Therapeutics (ASX:PTX) three years ago are up 307%Those who invested in Prescient Therapeutics (ASX:PTX) three years ago are up 307%
yahoo.com - August 25 at 2:47 AM
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our SpeakersA Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
msn.com - April 6 at 6:41 PM
Pernix Therapeutics Holdings Inc (PTX)Pernix Therapeutics Holdings Inc (PTX)
investing.com - March 30 at 8:52 PM
Mid-Afternoon Market Update: Vivint Solar Dips After Wider-Than-Expected Q3 Loss; Rackspace Shares Spike HigherMid-Afternoon Market Update: Vivint Solar Dips After Wider-Than-Expected Q3 Loss; Rackspace Shares Spike Higher
finance.yahoo.com - October 26 at 1:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

iShares Core Growth Allocation ETF logo

iShares Core Growth Allocation ETF

NYSEARCA:AOR
iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile. The Fund is designed for investors seeking moderate capital appreciation and opportunity for current income and capital preservation. The Fund's investment advisor is BlackRock Fund Advisors.
First Trust Multi Cap Value AlphaDEX Fund logo

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB
The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.
Pernix Therapeutics logo

Pernix Therapeutics

NASDAQ:PTX
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription drugs primarily for the United States market. It targets underserved therapeutic areas, such as central nervous system (CNS), including pain, neurology, and psychiatry. The company's products comprise Zohydro ER with BeadTek, an opioid agonist indicated for the management of pain; Silenor, a non-narcotic, non-scheduled, and non-addictive prescription sleep aid for the treatment of insomnia characterized by difficulty with sleep maintenance; and Treximet, a fixed dose combination product indicated for the treatment of acute migraine. Pernix Therapeutics Holdings, Inc. markets and sells its non-core products, including generics through its wholly owned subsidiaries; and markets its non-promoted products through distributors and trade partners. It serves drug wholesalers, specialty pharmacies, retail drug stores, mass merchandisers, and grocery store pharmacies. Pernix Therapeutics Holdings, Inc. was founded in 1996 and is headquartered in Morristown, New Jersey.